Skip to content

Effect of Bifidobacterium Adolescentis on Aging in Healthy Adults (45-65 Years)

Effect of Bifidobacterium Adolescentis on Aging in Healthy Adults (45-65 Years) - a Multicenter, Double-blind, Randomized, Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05603455
Enrollment
100
Registered
2022-11-02
Start date
2024-01-01
Completion date
2024-12-31
Last updated
2023-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults (45-65 Years)

Brief summary

This study will include middle-aged and elderly people aged 45-65 years to carry out the translational study of Bifidobacterium adolescentis, and design a double-blind, randomized controlled clinical trial according to strict inclusion/exclusion criteria, using aging-related functional indicators, intestinal flora, DNA methylation and other advanced aging characteristic examination methods to fully and accurately assess the effects and safety of Bifidobacterium adolescentis on aging, which has the advantages of strong safety, high practice and high credibility compared with previous clinical trial protocols, laying an important foundation for improving probiotic anti-aging and exploring the development of aging intervention programs suitable for the Chinese population.

Interventions

DIETARY_SUPPLEMENTBifidobacterium adolescentis

Supplement with Bifidobacterium adolescentis twice/day in morning and tonight for 6 months

DIETARY_SUPPLEMENTPlacebo

Placebo

Sponsors

Sir Run Run Shaw Hospital
CollaboratorOTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE (Subject, Caregiver, Investigator)

Masking description

Blinding of both the investigator (except for the investigator responsible for blinded product allocation) and the subject

Intervention model description

a multicenter, double-blind, randomized, controlled study

Eligibility

Sex/Gender
ALL
Age
45 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. 45-65 years of age. 2. Attending or consulting at the specialized outpatient clinics for aging diseases at 2nd Affiliated Hospital, School of Medicine, Zhejiang University and Sir Run Run Hospital, School of Medicine, Zhejiang University 3. Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

1. Known history of tumor. 2. women who are breastfeeding. 3. Those who wish to continue having children. 4. those who are unable to cooperate with investigations and testing 5. abuse of drugs, alcohol or other substances. 6. history of cardiac disease: atherosclerotic disease, heart failure, unstable angina, stable angina, etc. and chronic hypoxic diseases: emphysema, pulmonary heart disease, etc. 7. history of chronic gastrointestinal diseases (pancreatitis, IBS) and intestinal surgery. 8. endocrine disease with hyperthyroidism or cortisolism. 9. abnormal liver function, with ALT(Alanine transaminase)/AST(Aspartate aminotransferase) exceeding 2 times the upper limit of normal. 10. abnormal renal function with blood creatinine ≥ 133 μmol/L. 11. Type I diabetes or insulin-dependent type II diabetes. 12. poorly controlled chronic disease (hypertension, hyperlipidemia, type II diabetes, etc.) that is clinically unstable. 13. Vulnerable groups, including critically ill, mentally ill, cognitively impaired, minors, pregnant women, illiterate, etc.

Design outcomes

Primary

MeasureTime frameDescription
Markers for cell senescenceChange from Baseline the expression level of indicators at 6 monthsThe expression level of Markers for cell senescence was detected by qRT(quantitative real-time)-PCR(Polymerase Chain Reaction).The higher the Cycle Threshold,the lower the expression level of Markers for cell senescence, which means the healthier.
Cholesterol in mmol/LChange from Baseline Cholesterol at 6 monthsWithin the normal range(3.6\ 5.2 mmol/L), the health status is good
Telomere levelChange from Baseline Telomere level at 6 monthsTelomere level was detected by qRT(quantitative real-time)-PCR(Polymerase Chain reaction). The lower the Cycle Threshold,the higher the Telomere level,which means the healthier and younger.
Blood pressureChange from Baseline Systolic Blood Pressure and diastolic blood pressure at 6 monthsWithin the normal range, the health status is good
body fat percentageChange from Baseline body fat percentage at 6 monthsThe higher the body fat percentage, the better the health status
Aging Ai 3.0Change from Baseline physiological age calculated by Aging Ai 3.0 at 6 monthsCalculating physiological age through physical examination indicators.The lower the physiological age calculated by Aging Ai 3.0, the better the health status.
Fasting glucose in mmol/LChange from Baseline Fasting glucose at 6 monthsWithin the normal range(3.9\ 6.1 mmol/L), the health status is good
BMI(Body Mass Index)in kg/m^2 BMIChange from Baseline BMI in kg/m^2 at 6 monthsWithin the normal range, the health status is good
Epigenetic clockChange from Baseline physiological age calculated by Epigenetic clock at 6 monthsphysiological age was calculated by Epigenetic clock through DNA methylation.The lower the physiological age calculated by Epigenetic clock, the better the health status.
Bone density in g/cm^3Change from Baseline Bone density in g/cm3 at 6 monthsThe higher the Bone density, the better the health status
Triglycerides in mmol/LChange from Baseline Triglycerides at 6 monthsWithin the normal range(2.26\ 5.6 mmol/L), the health status is good

Secondary

MeasureTime frameDescription
Mini-Nutritional AssessmentChange from Baseline score at 6 monthsThe score (0-30)was calculated by Mini-Nutritional Assessment. The higher score calculated by Mini-Nutritional Assessment means a better outcome
The Medical Outcomes Study Short Form 36(SF-36)Change from Baseline score at 6 monthsThe score (36-145)was calculated by The Medical Outcomes Study Short Form 36. The higher score calculated by The Medical Outcomes Study Short Form 36 means a better outcome
Pittsburgh sleep quality indexChange from Baseline score at 6 monthsThe score (0-21)was calculated by Pittsburgh sleep quality index The higher score calculated by Pittsburgh sleep quality index means a worse outcome
Flora ClockChange from Baseline physiological age calculated by Flora Clock at 6 monthsCalculating physiological age through intestinal flora.The lower the physiological age calculated by Flora Clock, the better the health status.

Countries

China

Contacts

Primary Contactliangjing wang, doctor
wangljzju@zju.edu.cn+86 0571 87783759
Backup Contactchaochao xu, doctor
xucc0922@zju.edu.cn+86 0571 87783759

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026